1.
Chinese Journal of Microbiology and Immunology
;
(12): 395-400, 2018.
Article
in Chinese
| WPRIM
| ID: wpr-711418
ABSTRACT
Mycoplasma pneumoniae (M. pneumoniae) is one of the predominant pathogenic bacte-ria causing community acquired pneumonia. An epidemic of M. pneumoniae infection occurs every three to seven years worldwide. It can cause a variety of clinical symptoms. Since 2000, macrolide-resistant M. pneu-moniae strains have become increasingly common in many countries around the world and the drug resistance rate has reached as high as 100% in some area, which has posed a great threat to human health. This paper will review the status and mechanism of drug resistance in M. pneumoniae.